Begoña Bermejo Fraile-rekin lankidetzan egindako argitalpenak (4)

2024

  1. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

2019

  1. Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

    Breast Cancer Research and Treatment, Vol. 177, Núm. 1, pp. 115-125

2009

  1. Outcome differences between patients with node-negative breast cancer classified according to the st. gallen risk categories

    Clinical Breast Cancer, Vol. 9, Núm. 4, pp. 231-236

2006

  1. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor

    Annals of Oncology, Vol. 17, Núm. 11, pp. 1644-1649